EUVIMEDEUVIMED entdecken
Open Access

Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway

Xinhai Jiang, Weizhi Wang, Lijuan Lei, Tingting Feng, Yang Hu, Peng Liu, Yining Li, Ren Sheng, Yuyan Zhang, Shunwang Li, Jing Zhang, Yuhao Zhang und 5 weitere

International Journal of Biological Sciences · 2024 · 20 (10) · 3725-3741

DOI: 10.7150/ijbs.93465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Xinhai Jiang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, NHC Key Laboratory of Biotechnology for Antibiotics, National Center…. Hauptthemen laut MEDLINE: Leflunomide, Atherosclerosis, Lipid Metabolism, Signal Transduction. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeflunomideAtherosclerosisLipid MetabolismSignal TransductionDihydroorotate DehydrogenaseAntirheumatic AgentsAnimalsMiceHumansAMP-Activated Protein KinasesOxidoreductases Acting on CH-CH Group DonorsMaleMice, Inbred C57BLHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

AMPKDHODHatherosclerosisleflunomideteriflunomide

Substanzen

LeflunomideDihydroorotate DehydrogenaseAntirheumatic AgentsAMP-Activated Protein KinasesOxidoreductases Acting on CH-CH Group Donors

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, NHC Key Laboratory of Biotechnology for Antibiotics, National Center for New Microbial Drug Screening, Institute of Medicinal Biotechnolog…
  • Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200000, China.
  • Pharmacy Department, Peking Union Medical College Hospital, PUMC & CAMS, Beijing, 100730, China.
  • Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box CVRI, Rochester, NY 14642, USA.
  • Cardiology Department, Peking Union Medical College Hospital, PUMC & CAMS, No.1 Shuaifuyuan, Beijing, 100730, China.

Zitieren

APA

Jiang, X., Wang, W., Lei, L., Feng, T., Hu, Y., Liu, P., Li, Y., Sheng, R., Zhang, Y., Li, S., Zhang, J., Zhang, Y., Jin, Z. G., Tian, Z., Jiang, J., Xu, Y., & Si, S. (2024). Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway. International Journal of Biological Sciences, 20(10), 3725-3741. https://doi.org/10.7150/ijbs.93465

Vancouver

Jiang X, Wang W, Lei L, Feng T, Hu Y, Liu P, et al. Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway. International Journal of Biological Sciences. 2024;20(10):3725-3741. doi:10.7150/ijbs.93465

BibTeX
@article{Jiang2024,
  author = {Jiang, Xinhai and Wang, Weizhi and Lei, Lijuan and Feng, Tingting and Hu, Yang and Liu, Peng and Li, Yining and Sheng, Ren and Zhang, Yuyan and Li, Shunwang and Zhang, Jing and Zhang, Yuhao and Jin, Zheng-Gen and Tian, Zhuang and Jiang, Jiandong and Xu, Yanni and Si, Shuyi},
  title = {Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {10},
  pages = {3725--3741},
  doi = {10.7150/ijbs.93465}
}
Kostenlos starten →